Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by Jinal Bhiman and Prudence Kgagudi.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0,752
         
        
        
     
 
    
        
        - 
            Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages. Sci Rep. 2023 01 21; 13(1):1222.
            
            
                Score: 0,206
            
         
        
        - 
            Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage. Nat Commun. 2022 04 08; 13(1):1976.
            
            
                Score: 0,195
            
         
        
        - 
            A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories. Viruses. 2024 12 18; 16(12).
            
            
                Score: 0,059
            
         
        
        - 
            Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants. PLOS Glob Public Health. 2024; 4(4):e0002703.
            
            
                Score: 0,056
            
         
        
        - 
            Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants. medRxiv. 2023 Nov 20.
            
            
                Score: 0,055
            
         
        
        - 
            Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351). N Engl J Med. 2021 06 03; 384(22):2161-2163.
            
            
                Score: 0,046
            
         
        
        - 
            SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies. bioRxiv. 2021 Mar 11.
            
            
                Score: 0,045
            
         
        
        - 
            SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med. 2021 04; 27(4):622-625.
            
            
                Score: 0,045
            
         
        
        - 
            SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. bioRxiv. 2021 Mar 01.
            
            
                Score: 0,045